z-logo
open-access-imgOpen Access
Supplementary materials: endoglin in circulation is associated with favourable outcome for pemetrexed treatment in advanced non-small cell lung cancer
Author(s) -
Che-Hsing Li,
JiunnLiang Ko,
YuPing Hsiao,
Ming-Hung Tsao,
YenChein Lai,
ILun Hsin,
Yuting Kang,
GwoTarng Sheu,
MingFang Wu
Publication year - 2021
Publication title -
zenodo (cern european organization for nuclear research)
Language(s) - English
DOI - 10.5281/zenodo.4766680
Subject(s) - pemetrexed , lung cancer , medicine , oncology , circulation (fluid dynamics) , cancer , cancer research , chemotherapy , engineering , cisplatin , aerospace engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom